SMMT

Summit Therapeutics
D

SMMT

14.140
USD
-0.93
(-6.17%)
بعد الجلسة·14.180USD+0.040(+0.28%)
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
332,251
الربح لكل سهم
-1
العائد الربحي
-
P/E
-13
حجم السوق
11,308,661,801
أصول ذات صلة

العنوان: Summit Therapeutics

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate isridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.

أسئلة شائعة حول سهم Summit Therapeutics